Structure Therapeutics CSO Lin Xichen disposes of USD 401,255.43 in common shares
GPCR•Chief scientific officer sells shares after option exercise
Structure Therapeutics Chief Scientific Officer Lin Xichen cut direct ordinary share holdings to 228,960 on July 14.
Lin exercised options for 23,634 ordinary shares at $0.34 per share, then converted those shares into 7,878 American Depositary Shares.
Lin sold 7,878 American Depositary Shares at weighted average prices of $50.8 and $51.71 under a Rule 10b5-1 plan.
Lin ended the day with 1,600 American Depositary Shares, down from 7,878.
